Physician profile
Tyler Michael Bone
NPI 1013404284
$4,707.26
in general payments reported to CMS, 2019-2025
14 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,392 · 2024: $596 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,595 · Food and Beverage: $1,944 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,594.92 |
| Food and Beverage | $1,943.71 |
| Education | $168.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,832.80 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $395.53 | 2023-2025 | Dupixent |
| Medtronic, INC. | $348.27 | 2023-2024 | Fusion, Stealthstation S8 Platform, Propel |
| Aerin Medical INC. | $244.71 | 2023-2025 | |
| Glaxosmithkline, LLC. | $236.82 | 2023-2025 | Nucala |
| Stryker Corporation | $196.66 | 2023-2025 | Cmi, Stryker, Xpress Loprofile |
| Neurent Medical Limited | $138.92 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Genzyme Corporation | $129.87 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2024 | |
| Phathom Pharmaceuticals, INC. | $45.75 | 2025 | Voquezna |
| Boston Scientific Corporation | $24.43 | 2025 | Cds - Mct/Cem Monitoring |
| Pentax of America, INC. | $23.61 | 2023 | Vivideo |
| Merck Sharp & Dohme LLC | $21.93 | 2025 | Keytruda, Keytruda Qlex |
| Hikma Pharmaceuticals USA | $14.97 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Bone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.